secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABBOTT LABORATORIES (ABT)
CIK:        0000001800
Form:       8-K
Filed at:   2026-04-27T23:59:59+00:00
Accession:  0001104659-26-049434
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abbott adds Kevin Conroy to board; shareholders approve 2026 Incentive Stock Program
--------------------------------------------------------------------------------

- Kevin Conroy appointed to Abbott's Board of Directors effective April 24, 2026.
- Shareholders approved the 2026 Incentive Stock Program authorizing up to 140 million shares, replacing the 2017 plan.
- Board size increased from 12 to 13 directors via bylaw amendment effective April 24, 2026.
- The 2026 Program has a ten-year term and permits stock options, RSUs, performance awards, and other equity grants.
- All director nominees were elected; Ernst & Young ratified as independent auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/0001104659-26-049434-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/tm2612318d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-049434

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer